Aramune Technologies Limited

Aramune Technologies is a biotechnology startup based in the United Kingdom, founded in 2021. The company's slogan emphasizes its focus on providing sustainable alternatives for environmentally harmful ingredients in animal and consumer dietary and healthcare products. Aramune Technologies Ltd (ATL) is a spin-out company of Queen’s University Belfast (QUB) with an entirely disruptive approach to infection prevention in livestock, companion animals, and humans. The company has a small but highly experienced team dedicated to rapidly growing the business and developing new applications of its technology. Aramune Technologies recently secured a significant investment. In its last investment round at 25 May 2022, the company raised £800.00K in a Seed Round. The investors in this round included Qubis, Co-FundNI, and QUBIS Innovation Fund. The company's innovative approach to infection prevention and commitment to sustainability has attracted the attention of notable investors, indicating confidence in the potential of its technology. As Aramune Technologies continues to develop its solutions and expand its applications, it stands as a promising player in the biotechnology industry, poised for further growth and impact.